Geffner Michael, Chief Medical Officer of Immunovant, Inc. ($IMVT), sold shares on the open market six times in the last year, totaling about $248 thousand. His most recent sale occurred on October 22, 2025. These sales rank 7,984th among nearly 12,000 insiders in our database, where the average is 6.4 transactions worth $8.6 million. Geffner Michael made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 22, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 2595 | $19.03 | 217,958.0000 | 170,923,191 | 1.18% | 0.00% |
| Oct. 8, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 1272 | $16.30 | 220,553.0000 | 170,923,191 | 0.57% | 0.00% |
| July 23, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 2385 | $18.15 | 221,825.0000 | 170,923,191 | 1.06% | 0.00% |
| July 9, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 1160 | $17.24 | 224,210.0000 | 170,923,191 | 0.51% | 0.00% |
| April 23, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 2349 | $14.79 | 225,370.0000 | 0 | 1.03% | 0.00% |
| April 9, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 6169 | $12.99 | 227,719.0000 | 0 | 2.64% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | A | Stock Option (right to buy) | 143063 | $0.00 | 143,063.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | A | Common Stock | 101574 | $0.00 | 233,888.0000 | 0 | 76.77% | 0.00% |
| Jan. 22, 2025 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 2657 | $23.59 | 132,314.0000 | 0 | 1.97% | 0.00% |
| Oct. 23, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 3189 | $29.53 | 134,971.0000 | 0 | 2.31% | 0.00% |
| July 24, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 3456 | $27.76 | 138,160.0000 | 0 | 2.44% | 0.00% |
| April 24, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 3261 | $28.90 | 141,616.0000 | 0 | 2.25% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | A | Common Stock | 54978 | $0.00 | 144,877.0000 | 0 | 61.16% | 0.00% |
| Jan. 26, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 9948 | $37.91 | 90,052.0000 | 0 | 9.95% | 0.00% |
| Jan. 26, 2024 | Immunovant, Inc. | $IMVT | Geffner Michael | Chief Medical Officer | S | Common Stock | 153 | $38.45 | 89,899.0000 | 0 | 0.17% | 0.00% |